Upstart Holdings Q1 Results Beat Street View

Shares of Upstart Holdings, Inc. (UPST) gained over 17% on extended trading session on Tuesday after its profit and revenues of the first quarter trumped Wall Street estimates.

Upstart's first-quarter profit rose to $10.1 million or $0.11 per share from $1.5 million or breakeven per share. Adjusted earnings for the quarter were $0.22 per share, up from $0.05 per share last year.

Revenues for the quarter surged 90% to $121.3 million from $64.0 million last year.

Analysts polled by Thomson Reuters expected earnings of $0.15 per share and revenues of $116.06 million for the quarter.

"Upstart is delivering a combination of growth and profits that is rare in FinTech and in the technology industry overall," said Dave Girouard, CEO of Upstart.

He added, "The advantages of AI in lending are becoming more apparent by the day and Upstart is synonymous with this newly emerging category."

Looking forward to the second quarter, Upstart expects revenues of $150 million to $160 million. Analysts currently estimate revenues of $117.13 million.

For the full year 2021, the company now expects revenue of around $600 million, up from prior guidance of $500 million. Analysts currently estimate revenues of $503.18 million.

UPST closed Tuesday's trading at $89.44, up $1.23 or 1.39%, on the Nasdaq. The stock further gained $15.26 or 17.06% in the after-hours trade.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Elon Musk's brain implant firm Neuralink said it has received approval from the U.S. Food and Drug Administration to conduct first-in-human clinical trials. In a tweet, Neuralink said, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study! T.W. Garner Food Co. is recalling 50,688 bottles of 12 oz. Texas Pete Buffalo Wing Sauce citing undeclared soy, the U.S. Food and Drug Administration said. The agency noted that some of the bottles may contain Texas Pete Extra Mild Wing Sauce which contains soy. The recall involves Texas Pete Buffalo Wing Sauce with best used by 120623T 065239 UPC 0 75500 10011 6. The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults. Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) has been approved to treat adults who are at high...
Follow RTT